Phil Okala has been selected to lead UPHS business development efforts, succeeding Mike Dandorph who left Rush Medical Center in Chicago. A dedicated colleague since 2007, Okala will oversee business development, marketing, service line integration, network development, and patient facilitated services. His responsibilities for the cancer and neuroscience service lines have been transitioned to colleagues in Business Development.
Okala successfully led the implementation of an integrated operating model within the Abramson Cancer Center by evolving several discrete practice models into a highly coordinated, multidisciplinary environment, that worked closely with physician partners to develop best practices with strong returns both in improved quality and in financial performance. He improved linkages between inpatient and outpatient operations and quality initiatives and worked to establish a multi-departmental shared governance structure. Okala’s work to strengthen our regional referral network through deepening existing relationships and adding new strategic affiliations has resulted in increased vital referrals for tertiary and quaternary care.